Accepting Applications to the Genomic Science and Health Equity Postdoctoral Fellowship

If your email program has trouble displaying this email, view as a webpage. FDA Office of Minority Health and Health Equity April 16, 2021 Accepting Applications to the Genomic Science and Health Equity Postdoctoral Fellowship The FDA Office of Minority Health and Health Equity (OMHHE) and the NIH National Human Genome Research Institute (NHGRI) are co-sponsoring a newly established Genomic Science and Health Equity Postdoctoral Fellowship Program. This program will prepare the fellow to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity. The fellow will be trained in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics and devices from the bench to the bedside. The fellow will pursue genomics research related to transfusion support for sickle cell disease (SCD), a health disparity condition that primarily affects African Americans in the United States. The successful candidate will complete a research project to produce reference reagents for blood group genotyping, which will optimize transfusion support for patients with SCD. Applications are being accepted and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2021. For more information about this fellowship, visit the Postdoctoral Fellowship in Genomic Science and Health Equity webpage.   Visit the FDA OMHHE website and follow us on Twitter at @FDAHealthEquity  "Creating a world where health equity is a reality for all." www.fda.gov/HealthEquity

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA